{"url_path":"/sec/pbm/10-k/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","accession_number":"0001213900-26-070607","cik":"0001985062","ticker":"PBM","issuer_name":"PSYENCE BIOMEDICAL LTD.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","primary_entity_key":"0001985062","primary_entity_name":"PSYENCE BIOMEDICAL LTD."},"word_count":817,"has_tables":true,"body_markdown":"**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n** **\n\n**FORM 20-F**\n\n** **\n\n**(Mark One)**\n\n**☐ REGISTRATION STATEMENT PURSUANT TO SECTION\n12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n** **\n\n**OR**\n\n** **\n\n**☒ ANNUAL REPORT PURSUANT TO SECTION 13\nOR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the fiscal year ended March 31, 2026**\n\n** **\n\n**OR**\n\n** **\n\n**☐ TRANSITION REPORT PURSUANT TO SECTION\n13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n** **\n\n**OR**\n\n** **\n\n**☐ SHELL COMPANY REPORT PURSUANT TO SECTION\n13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n** **\n\n**Date of event requiring this shell company report:**\n\n** **\n\n**Commission File Number: 001-41937**\n\n** **\n\n**Psyence Biomedical Ltd.**\n\n**(Exact name of Registrant as specified in its\ncharter)**\n\n** **\n\n**Not applicable**   **Ontario, Canada**\n\n**(Translation of Registrant’s\nname into English)**   **(Jurisdiction of incorporation\nor organization)**\n\n** **\n\n**121 Richmond Street West**\n\n**Penthouse Suite 1300**\n\n**Toronto, Ontario M5H 2K1**\n\n**+1 (416) 477-1708**\n\n**(Address of principal executive offices)**\n\n** **\n\n**Copy to:**\n\n**Jody Aufrichtig**\n\n**121 Richmond Street West**\n\n**Penthouse Suite 1300**\n\n**Toronto, Ontario M5H 2K1**\n\n**+1 (416) 477-1708**\n\n**(Name, Telephone, Email and/or Facsimile number\nand Address of Company Contact Person)**\n\n** **\n\n**Securities registered or to be registered pursuant\nto Section 12(b) of the Act:**\n\n** **\n\n**Title of each class**   **Trading Symbol(s)**   **Name of each exchange\non which registered**\n\n**Common shares, without par value**   **PBM**   **The Nasdaq Stock Market LLC**\n\n**Warrants, each exercisable to\npurchase one Common Share at an\nexercise price of $42,963.28 per share**   **PBMWW**   **The Nasdaq Stock Market LLC**\n\n \n\n**Securities registered or to be registered pursuant\nto Section 12(g) of the Act: None**\n\n** **\n\n**Securities for which there is a reporting obligation\npursuant to Section 15(d) of the Act: None**\n\n** **\n\n \n\nThe number of the issuer’s outstanding common shares as of March 31,\n2026 was 2,293,277 common shares.\n\n \n\nIndicate by check mark if the registrant is a well-known seasoned issuer,\nas defined in Rule 405 of the Securities Act. Yes ☐   No ☒\n\n \n\nIf this report is an annual or transition report, indicate by check\nmark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes ☐   No ☒\n\n \n\nIndicate by check mark whether the registrant: (1) has filed all\nreports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months\n(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements\nfor the past 90 days. Yes ☒   No ☐\n\n \n\nIndicate by check mark whether the registrant has submitted electronically\nevery Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during\nthe preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒   No ☐\n\n \n\nIndicate by check mark whether the registrant is a large accelerated\nfiler, an accelerated filer, or a non-accelerated filer, or an emerging growth company. See definition of “accelerated filer,”\n“large accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒\n\n        Emerging growth company ☒\n\n \n\nIf an emerging growth company that prepares its financial statements\nin accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant has filed a report on\nand attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of\nthe Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐\n\n \n\nIf securities are registered pursuant to Section 12(b) of\nthe Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an\nerror to previously issued financial statements. ☐\n\n \n\nIndicate by check mark whether any of those error corrections are restatements\nthat required a recovery analysis of incentive based compensation received by any of the registrant’s executive officers during\nthe relevant recovery period pursuant to §240.10D-1(b). ☐\n\n \n\nIndicate by check mark which basis of accounting the registrant has\nused to prepare the financial statements included in this filing:\n\n \n\nU.S. GAAP ☐ International Financial Reporting Standards as issue by the International Accounting Standards Board ☒ Other ☐\n\n \n\nIf “Other” has been checked in response to the previous\nquestion indicate by check mark which financial statement item the registrant has elected to follow. Item 17 ☐ Item 18 ☐\n\n \n\nIf this is an annual report, indicate by check\nmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\n \n\n \n\n \n\n**TABLE OF CONTENTS**\n\n \n\n \n \n \n \n**Page**\n\n \n \n[CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS](#a_001)\n \nii\n\n**PART I**\n \n \n \n1"}